Quantcast

Latest VirtualScopics Inc. Stories

2014-08-21 08:28:37

ROCHESTER, N.Y., Aug. 21, 2014 /PRNewswire/ -- The board of directors of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that James Groff, 44, has been named chief financial officer, effective immediately. Mr. Groff has held the role of acting chief financial officer since August 2013. He joined VirtualScopics in January 2006 as an accounting manager and was promoted to controller in February 2013. "When the board of...

2014-08-14 08:28:11

ROCHESTER, N.Y., Aug. 14, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today reported the financial results for the second quarter and six months ended June 30, 2014. Awards outstanding and bookings for the first six months of 2014 increased to $17.6 million, more than double the $7.7 million reported during the same period in 2013. Year to date 2014 awards outstanding and bookings are approximately $23.5 million, 115% of...

2014-08-05 08:35:25

ROCHESTER, N.Y., Aug. 5, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its second quarter and six months 2014 financial results before the market opens on Thursday, August 14, 2014. Eric T. Converse, president and chief executive officer, and Jim Groff, acting chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a...

2014-07-23 16:27:11

ROCHESTER, N.Y., July 23, 2014 /PRNewswire/ -- The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse, 48, has been named president and chief executive officer, effective immediately. Mr. Converse joined the company's Board of Directors in August 2013 and has held the positions of interim president and chief executive officer since October 25, 2013. Dr. Charles E. Phelps, Ph.D.,...

2014-07-14 04:21:30

ROCHESTER, N.Y. and LONDON, July 14, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP) and IXICO plc (AIM: IXI) jointly announced today the formation of a Scientific Advisory Board that will benefit both companies. Dr. Edward Ashton, Ph.D., chief scientific officer, VirtualScopics, will chair the Board which initially will have seven members. "The formation of this joint Scientific Advisory Board is an important initiative of the international commercial and operational alliance we...

2014-06-30 04:21:37

ROCHESTER, N.Y. and LONDON, June 30, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, announced today they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania. The office will be located at 220 Union Square Drive, located within the Union Square...

2014-06-27 08:25:47

LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ -- Commercial and Operational Alliance to Provide Clinical Trials Industry With Global Capabilities and a Full Range of Therapeutic Areas and Modality Expertise IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today said they have signed an Alliance Framework Agreement and...

2014-06-27 04:21:21

ROCHESTER, N.Y. and LONDON, June 27, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of...

2014-06-20 08:24:04

ROCHESTER, N.Y., June 20, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that Charles E. Phelps, Ph.D., 71, has been named chairman of the company's Board of Directors. Dr. Phelps has served as a director of the company since December 2005. Dr. Phelps, University Professor and Provost Emeritus at the University of Rochester, retired from the position of provost of the University of Rochester in July...

2014-06-19 16:26:32

ROCHESTER, N.Y., June 19, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all four proposals contained in the company's 2014 proxy statement. The outcome of yesterday's vote at the Annual Meeting of Shareholders is as follows: -- Re-elected to the Board of Directors to serve until the 2015 Annual Meeting are Robert G. Klimasewski, Eric T. Converse,...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related